Winslow, Evans & Crocker, Inc. - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 250 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
Winslow, Evans & Crocker, Inc. ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2018$32,964,000
-2.5%
1,7580.0%0.01%0.0%
Q4 2017$33,824,000
+7.7%
1,7580.0%0.01%
+10.0%
Q3 2017$31,416,000
+0.1%
1,7580.0%0.01%
+11.1%
Q2 2017$31,398,000
+23.2%
1,7580.0%0.01%
+12.5%
Q1 2017$25,492,000
-21.3%
1,7580.0%0.01%
-20.0%
Q4 2016$32,384,000
-51.4%
1,758
-13.9%
0.01%0.0%
Q3 2016$66,700,000
+440.9%
2,042
+166.6%
0.01%
+150.0%
Q2 2016$12,332,0007660.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$4,884,3754.79%
SHAKER INVESTMENTS LLC/OH 82,253$3,084,4881.72%
Mesirow Institutional Investment Management, Inc. 325,669$12,212,5881.33%
Portolan Capital Management 340,593$12,772,2381.22%
OBERWEIS ASSET MANAGEMENT INC/ 178,200$6,682,5001.04%
Granite Investment Partners, LLC 536,821$20,130,7880.84%
Capital Impact Advisors, LLC 15,304$573,9000.70%
Hillsdale Investment Management Inc. 155,038$5,813,9260.50%
GLOBEFLEX CAPITAL L P 89,192$3,344,7000.41%
Jackson Creek Investment Advisors LLC 25,877$9700.41%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders